Kamis 11 March 2010

Profile | FAQs | Belanja Online | Delivery Service | Register |Member Area

Riset Pendukung Noni

October 12, 2008 Oleh tahitianonijuice  
Artikel masuk kategori Riset Noni

Referensi untuk: Morinda citrifolia (Noni): Review Literatur dan pengetahuan terbaru dalam riset noni.

1. Zhu YP, Woerdenbag HJ . Traditional Chinese herbal medicine. Pharm World Sci 1995; 17: 103-12.

2. Whistler WA. Traditional and herbal medicine in the cook islands. J Ethnopharm 1985; 13: 239-80.

3. Singh Y, Ikahihifo T, Panuve M, Slatter C. Folk medicine in Tonga. A study on the use of herbal medicines for obstetric and gynacological conditions and disorders. J Ethnopharm 1984; 12: 305-25.

4. Tabrah FL, Eveleth BM. Evaluation of the effectiveness of ancient Hawaiian medicine. Hawaii Med J 1966; 25: 223-30.

5. Krauss B. Plants in Hawaiian culture. Honolulu: University of Hawaii Press; 1993. p103, p252.

6. Whistler W. Tongan herbal medicine. Isle Botanica, Honolulu, Hawaii, 1992. p 89-90.

7. Bruggnecate JT. Native plants can heal your wounds. Honolulu Star-Bulletin Local News 1992 Feb 2.

8. Neal M. Gardens of Hawaii. Honolulu, Hawaii: Bishop Museum Press; 1965. p 804.

9. Cheeseman TF. The flora of raratonga, the chief island of the cook group. v 6. London: Linnean Soc;1903. p 261-313.

10. Seemann B. Flora V. A description of the plants of the Viti or Fiji is lands with an account of their history, us es, and properties. London: L Reeve and Co; 1866. p 1865-73.

11. Maiden JH. Useful native plants of Australia including Tasmania. Sydney: Tuner and Henderson Publisher; 1889. p 45.

12. Morton JF. The ocean-going Noni, or Indian mulberry (Morinda citrifolia, Rubiaceae) and some of its ‘colorful’ relatives. Economic Botany 1992; 46: 241-56.

13. Merrill ED. Noni (Morinda citrifolia) as an edible plant. In: Technical manual: emergency food plants and poisonous plants of the islands of the pacific. Washington DC: US Government Printing Office; 1943.

14. Abbott IA. La’au Hawaii’ traditional Hawaiian uses of plants. Honolulu, Hawaii: Bishop Museum Press; 1992. p 97-100.

15. Swanholm CE, St John H, Scheuer PJ. A survey of alkaloids in Hawaiian plants. Pacific Science 1959; 13: 295-305.

16. Solomon N. The tropical fruit with 101 medicinal uses, NONI juice. 2nd ed. Woodland Publishing; 1999.

17. Allen WH, London C. Some information on the ethnobotanical properties of Noni (Mor inda citr ifolia). In: The useful plants of india; 1873.

18. Abbott IA. The geographic origin of the plants most commonly used for medicine by Hawaiians. J Ethnopharmacol 1985; 14: 213-22.

19. Bushnell OA, Fukuda M, Makinodian T. The antibacterial properties of some plants found in Hawaii. Pacific Science 1950; 4: 167-83.

20. Pride Publishing, Noni: Polynesia’s natural pharmacy. 1997. p 13.

21. Levand O, Larson HO. Some chemical cons tituents of Morinda citrifolia. Planta Med 1979; 36: 186-7.

22. Farine JP, Legal L, Moreteau B, Le Quere JL. Volatile components of ripe fruits of Mor inda citr ifolia and their effects on Drosophila. Phytochemistry 1996; 41: 433-8.

23. Higa I, Fuyama Y. Genetics of food preference in Drosophila sechellia. 1. Responses to food attractants. Genetica 1993; 88: 129-36.

24. Peerzada N, Renaud S, Ryan P. Vitamin C and elemental compos ition of some bushfruits. J Plant Nutrition 1990; 13: 787-93.

25. Budavari S, O’Neil MJ, Smith A, Heckelman PE. In: The Merck Index. An encyclopedia of chemicals, drugs , and biologicals. 11th ed. Merck & Co Inc, Rathway, New Jersey, 1989.

26. Moorthy NK, Reddy GS. Preliminary phytochemical and pharmacological study of Morinda citrifolia, Linn. Antiseptic 1970; 67: 167-71.

27. Daulatabad CD, Mulla GM, Mirajikar AM. Riconoleic acid in Morinda citrifolia seed oil. Oil Technologists’ Association of India 1989; 21: 26-7.

28. Balakrishna S, Seshadri TR, Venkataramani B. Special chemical component of commercial woods and related plant materials: Part X-Heartwood of Morinda citrifolia Linn. J Sci Industrial Res 1961; 20B:331-3.

29. Legal L, David JR, Jallon JM. Molecular basis of Morinda citrifolia (L.): toxicity on Drosophila. J Chem Ecolog 1994; 20: 1931-43.

30. Singh J, Tiwari RD. Flavone glycosides from the flowers of Morinda citrifolia. J Indian Chem Soc 1976; 53: 424.

31. Simonsen JL. Note on the constituents of Morinda citrifolia. J Chem Soc 1920; 117: 561-4.

32. Heinicke R. The pharmacologically active ingredient of Noni. Bulletin of the National Tropical Botanical Garden, 1985.

33. Wang M, Kikuzaki H, Csiszar K, Boyd CD, Maunakea A, Fong SF, et al. Novel trisaccharide fatty acid ester identified from the fruits of Morinda citrifolia (Noni). J Agric Food Chem 1999; 47: 4880-2.

34. Sang S, He K, Liu G, Zhu N, Cheng X, Wang M, et al. A new unusual iridoid with inhibition of activator protein-1 (AP-1) from the leaves of Morinda citrifolia L. Org Lett 2001; 3:1307-9.

35. Sang S, Cheng X, Zhu N, Wang M, Jhoo JW, Stark RE, et al. Iridoid glycosides from the leaves of Morinda citrifolia. J Nat Prod 2001; 64: 799-800.

36. Liu G, Bode A, Ma WY, Sang S, Ho CT, Dong Z. Two novel glycos ides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell trans formation in the mouse epidermal JB6 cell line. Cancer Res 2001; 61: 5749-56.

37. Sang S, Cheng X, Zhu N, Stark RE, Badmaev V, Ghai G, et al. Flavonolglycosides and novel iridoid glycoside from the leaves of Morinda citrifolia. J Agric Food Chem 2001; 49: 4478-81.

38. Wang M, Kikuzaki H, Jin Y, Nakatani N, Zhu N, Csiszar K, et al. Novel glycosides from noni (Morinda citrifolia). J Nat Prod 2000; 63: 1182-3.

39. Duke JA. Handbook of phytochemicals. Boca Raton, FL: CRC Publishing; 1992.

40. Heinicke R. The Xeronine sys tem: a new cellular mechanism that explains the health promoting action of NONI and Bromelian. Direct Source Publishing; 2001.

41. Atkinson N. Antibacterial substances from flowering plants. 3. Antibacterial activity of dried Australian plants by a rapid direct plate test. Australian J Exper Biol 1956; 34: 17-26.

42. Leach AJ, Leach DN, Leach GJ . Antibacterial activity of some medicinal plants of Papua New Guinea. Sci New Guinea 1988; 14: 1-7.

43. Locher CP, Burch MT, Mower HF, Beres tecky J , Davis H, Van Poel B, et al. Anti-microbiol activity and anti-complement activity of extract obtained from s elected Hawaiian medicinal plants. J Ethnopharm 1995; 49: 23-32.

44. Duncan SH, Flint HJ, Stewart CS. Inhibitory activity of gut bacteria against Es cherichia coli 0157 mediated by dietary plant metabolites. FEMS Microbiol Lett 1998; 164: 283-58.

45. Umezawa K. Isolation of 1-methoxy-2-foremyl-3-hydroxyanthraquinone from M citrifolia and neoplasm inhibitors containing the same. Japan Kokai Tokyo Koho JP 06 87, 736 (94-87, 736) Appl 1992; 92/264, 311 07.

46. American Chemical Society: Noni plant may yield new drugs to fight tuberculosis. Press releas e the 2000 International Chemical Congress of Pacific Basin Societies. 2000.

47. Author unlis ted. Noni plant may help TB. AIDS patient care STDS 2001; 15: 175.

48. Hirazumi A, Furusawa E, Chou SC, Hokama Y. Anticancer activity of Morinda citrifolia (noni) on intraperitoneally implanted Lewis lung carcinoma in syngeneic mice. Proc West
    Pharmacol Soc 1994; 37: 145-6.

49. Hirazumi A, Furusawa E, Chou SC, Hokama Y. Immunomodulation contributes to the anticancer activity of Morinda citrifolia (noni) fruit juice. Proc West Pharmacol Soc 1996;
    39: 7-9.

50. Hirazumi A, Furus awa E. An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) with antitumour activity. Phytother Res 1999; 13: 380-7.

51. Hiramatsu T, Imoto M, Koyano T, Umezawa K. Induction of normal p henotypes in ras -trans fo rmed cells by damnacanthal from Morinda citrifolia. Cancer Lett 1993; 73: 161-6.

52. Hiwasa T, Arase Y, Chen Z, Kita K, Umezawa K, Ito H, et al. Stimulation of ultraviolet-induced apoptos is of human fibroblast UVr-1 cells by tyrosine kinas e inhibitors. FEBS Lett 1999; 444: 173-6.

53. Sang S, He K, Liu G, Zhu N, Cheng X, Wang M, et al. A new unusual iridoid with inhibition of activator protein-1 (AP-1) from the leaves of Morinda citrifolia L. Org Lett 2001; 3: 1307-9.

54. Raj RK. Screening of indigenous plants for anthelmintic action against humanAscaris Lumbricoides: Part-II. Indian J Physiol Pharmacol 1975; 19: 47-9.

55. Younos C, Rolland A, Fleurentin J, Lanhers MC, Miss lin R, Mortier F. Analgesic and behavioural effects of Morinda citrifolia. Planta Med 1990; 56: 430-4.

56. Youngken HW, Jenkins H J, Butler CL. Studies on Morinda citrifolia L. II. J Am Pharm Assoc 1960; 49: 271-3.

57. Youngken HW. A study of the root of Morinda citrifolia Linn, I. J Am Pharm Assoc 1958; 47: 162-5.

58. Davison C. Hawaiian medicine. The Queen’s Hospital Bulletin with Palama Clinic Section 1927; 4: 2-5.

59. Asahina AY, Ebesu JSM, Ichinotsubo D, Tongson J, Hokama Y. Effect of okadaic acid (OA) and Noni fruit extraction in the synthesis of tumor necrosis factor-a (TNF-a) by peripheral blood mononuclear (PBN) cells in vitro. The Procedings of the International Symposium of Ciguatera and Marine Natural Products; 1994. p 197-205.

60. Hokama Y. The effect of Noni fruit extract (Morinda citrifolia, Indian mulberry) on thymocytes of BALB/c mouse. FASEB J 1993; 7: A866.

61. Langford J , Doughty A, Wang MY, Clayton L, Babich M. Effects of Morinda citrifolia on auditory function and quality of life in patients with decreas ed bone mineral density and auditory function. J Complementary & Alternative Med Submitted, 2002.

62. Acute oral toxicity s tudy in rats -limit test: TAHITIAN NONI® Juice. 1999 Oct 6. Product Safety Labs (Eurofins Scientific, Inc). East Brunswick, New Jersey, USA.

63. Kaaber K. TAHITIAN NONI® Juice: active systemic anaphylaxis test in the guinea pig. 2000 Feb 18 . Scantox BiologiskLaboratorium A/S, DK-426, Lille Skensved, Denmark.

64. Guinea pig antigenicity study. TAHITIAN NONI® juice. 2000 Feb 29. Product Safety Labs (Eurofins Scientific, Inc). East Brunswick, New Jersey, USA.

65. Glerup P. TAHITIAN TNJ: A 13-week oral (gavage) toxicity study in rats. 2001 May. Scantox Biologisk Laboratorium A/S, DK-426. Lille Skensved, Denmark.

66. Degener O. In: Plants of Hawaii national park illustrative of plants and cus toms of the south seas . Photo-Lithoprint Reproductions, Braun-Brumfield, Inc. Ann Arbor, Michigan. 1973.

67. Rock JF. In: The indigenous trees of the Hawaiian islands. Patronage. Honolulu, Hawaii. 1913.

68. Stone BC. “Morinda Linnaeus”. Micronesica 1970; 6: 551-2.

69. Sturtevant EL. Sturtevant’s notes on edible plants (Hedrick UP, editor). Albany, New York: JB Lyon Co; 1919. p 368.

70. Terra JA. Tropical Vegetables. Ams terdam: Knoninklyk Ins tituut voor de Tropen; 1996. p 61.

71. Turbott IG. Diets , Gilbert and Ellice Islands Colony. J Polynesian Soc 1949; 58: 36-46.

72. Uhe G. In: Wayside plants of the south pacific. Stockton House R.D. 3. Albany, New Zealand. 1974.

73. Wilder GP. In: The flora of Makatea. Bernice P. Bishop Museum Bulletin 120. Honolulu, Hawaii: Bishop Museum Press; 1934.

74. Yuncker TG. In: The flora of Niue Island. Bernice P. Bishop Museum Bulletin, 178. Honolulu, Hawaii: Bishop Museum Press; 1943.

75. Solomon N. Nature’s amazing healer, Noni. Pleas ant Grove, Utah: Woodland Publishing; 1998.

76. Solomon N. The Noni phenomenon. Discover the powerful tropical healer that fights cancer, lowers high blood pres sure and relieves chronic pain. Direct Source Publishing; 1999.

77. Solomon N. TAHITIAN NONI Juice: How much, how often, for what. Direct Source Publishing; 2000.

78. Solomon N. TAHITIAN NONI® Juice—The pain fighter (arthritis/pain). Direct Source Publishing; 2001.

79. Sharps J. NONI juice, A pres cription for the good health. Integrated Health Service; 2000.

80. Veith I. Translated “Yellow Emperor’s Classic of Internal Medicine” (2500 BC); 2002.

81. Du B, You S. Present situation in preventing and treating liver fibrosis with TCM drugs. J Tradit Chin Med 2001; 21: 147-52.

82. American Cancer Society: Statistics of cancer incidence. 2002.

83. Lichtenstein P, Holm NV, Verkas alo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer — analys es of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000 343: 78-85.

84. Perera P. Molecular epidemiology and prevention of cancer. Environ Health Perspect 1995; 103 (Suppl 8): 2336.

85. American Ins titute for Cancer Research: 11th Annual Research Conference on Diet, Nutrition and Cancer. Washington DC. 2001.

86. Rus so J , Russo IH. Experimentally induced mammary tumors in rats . Breast Cancer Res Treat 1996; 39: 7-20.

87. elSisie AE, Hall P, Sim WL, Earnest DL., Sipes IG. Characterization of vitamin A potentiation of carbon tetrachlorideinduced liver injury. Toxicol Appl Pharmacol 1993; 119: 280-8.

88. Santella RM. DNA damage as an intermediate biomarker in intervention studies. Proc Soc Exp Biol Med 1997; 216: 166-71.

89. Kens ler TW, Groopman JD. Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoint in chemoprevention trials. J Cell Biochem Suppl 1996; 25: 85-91.

90. Rabes HM. DNA adducts and cell cycle. J Cancer Res Clin Oncol 1986; 112: 189-95.

91. Hemminki K. DNA adducts, mutations and cancer. Carinogenesis 1993; 14: 2007-12.

92. Poirier MC, Weston A. Human DNA adduct measurements: state of the art. Environ Health Perspect 1996; 104 Suppl 5: 883-93.

93. Slaga TJ. Multistage skin carcinogenesis: an useful model for the s tudy of the chemopreventionn of cancer. Acta Pharmacol Toxicol 1984; 55 Suppl 2: 107-24.

94. Wang MY, Anderson G, Nowicki D. Preventive effect of Morinda citrifolia (Noni) at the initiation s tage of mammary breas t cancer induced by 7,12-dimethylbenz(a)-anthracen (DMBA) in female Sprague-Dawley rats. The Proceedings of the Frontiers in cancer prevention research, AACR, Boston, 2002 Oct 17.

95. Wang MY, Nowicki D, Anderson, G. Protective effect of Mor inda citr ifolia on hepatic injury induced by a liver carcinogen. The Proceedings of 93rd Annual Meeting of American Association for Cancer Research 2002; 43: 477.

96. Wang MY, Su C, Nowicki D, Jensen J, Anderson G. Morinda citrifolia and cancer prevention. J Nutrition 2001; 131 (11S): 3151S.

97. Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect 1997; 105 Suppl 4: 875-82.

98. Bartsch H, Nair J . New DNA-das ed biomarkers for oxidative stress and cancer chemoprevention studies. Eur J Cancer 2000; 36:1229-34.

99. Wang MY, Lieher, JG. Induction by estrogens of lipid peroxidation and lipid peroxide derived malondialdehyde-DNA adducts in male Syrian hams ters : role of lipid peroxidation in estrogen induced kidney carcinogenesis. Carcinogenesis1995; 16: 1941-5.

100. Diplock AT, Charleux JL, Crozier-Willi G, Rice-Evans C, Roberfroid M, Stahi W, et al. Functional food science and defense against reactive oxidative species. Br J Nutr 1998; 80 Suppl 1: S77-112.

101. Weisburger JH, Rivenson A, Garr K, Aliaga C. Tea, or tea and milk, inhibit mammary gland and colon carcinogenesis in rats. Cancer Lett 1997; 114: 323-7.

102. Nishikimi M, Rao NA, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 1972; 46: 849-54.

103. Auerbach BJ , Kiely JS, Cornicell JA. A spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid. Anal Biochem 1992; 201: 375-80.

104. Wang MY, Su C. Cancer preventive effect of Mor inda citrifolia (Noni). Ann NY Acad Sci 2001; 952: 161-8.

105. Wang MY, Su C. Cancer preventive effect of Morinda citrifolia. The proceedings of the Strang International Cancer Prevention Conference. 2000 Nov 10-11, New York.

106. Wang MY, Su C, Nowicki D, Jensen J, Anderson G. Protective effect of Morinda citrifolia in carbontetrachloride-induced liver injury model: A light and electron microscopic study. The Proceedings of the Eicosanoids and other Bioactive Lipids in Cancer, Inflammatory and Related Diseas es, the 7th Annual Conference, 2001 Oct 16. Loews Vanderbilt Plaza, Nashville, Tennessee, USA.

107. Burns DM. Cigarette smoking among the elderly: disease consequences and the benefits of cess ation. Am J Health Promot 2000; 14: 357-61.

108. Meerson FZ, Kagon VE, Kozolov YP, Belkina IM, Penko A. The role of lipid peroxidation in pathogenes is of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol 1982; 77: 465-85.

109. Chow CK. Cigarette smoking and oxidative damage in the lung. Ann NY Acad Sci 1993; 686: 289-98.

110. US Department of Health and Human Services. Reducing the health consequences of smoking 25 years of progress. A report of the Surgeon General. DHHHS Publ# (CDC) 1989; 89: 8411.

111. Kozumbo WJ, Trush MA, Kens ler TW. Are free radicals involved in tumor promotion? Chem Biol Interact 1985; 54: 199-207.

112. Hemminki K, Kumar R, Bykov VJ, louhelainen J, Vodicka P. Future research directions in the use of biomarkers. Environ Health Perspect 1996; 104 Suppl 3: 459-64.

113. Wang MY, Dhingra K, Hittelman WN, Lieher JG, Andrade M, Li D. Lipid peroxdation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemology, Biomarkers & Prevention 1996; 5: 705-10.

114. World Cancer Res earch Fund and American Institute for Cancer Res earch: Food, nutrition, and the prevention of cancer: a global perspective. Published by the American Institute for Cancer Research, 1997.

115. Fontham ET. Protective dietary factors and lung cancer. Int J Epidemiol 1990;19 Suppl 1:S32-42.

116. Wang MY, Nowicki D, Anderson G, Su C, Jensen J. Protective effects of Morinda citrifolia on plasma superoxides (SAR) and lipid peroxides (LPO) in current smokers. The Proceedings of XIth Biennial Meeting of the Society for Free Radical Research International. July 16-20, 2002. Ren’e Des cartes University. Paris, France. in press.

117. Natarajan K, Mori N, Artemov D, Bhujwalla ZM. Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression. Neoplasia 2002; 4:409-16.

118. Yao M, Song DH, Rana B, Wolfe MM. COX-2 selective inhibition revers es the trophic properties of gas trin in colorectal cancer. Br J Cancer 2002; 87: 574-9.

119. Takahashi T, Kozaki K, Yatabe Y, Achiwa H, HidaT. Increased expres sion of COX-2 in the development of human lung cancer. J Environ Pathol Toxicol Oncol 2002; 21: 177-81.

120. Langman MJ, Cheng KK, Gilman EA, Lancashire RJ. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research databas e. BMJ 2000; 320: 1642-6.

121. Decensi A, Cos ta A. Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer. Eur J Cancer 2000; 36: 694-709.

122. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994; 5: 138-46.

123. Brigati C, Noonan DM, Albini A, Benelli R. Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 2002; 19: 247-58.

124. McMurray RW, Hardy KJ. COX-2 inhibitors: today and tomorrow. Am J Med Sci 2002; 323: 181-8.

125. Dermond O, Ruegg C. Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs : emerging mechanisms and therapeutic perspective. Drug Resist Updat 2001; 4: 314-21.

126. Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, et al. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of no-small cell lung carcinoma. Clin Cancer Res 2000; 6: 4739-44.

127. Colville-Nash PR, Gilroy DW, Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation. Biodrug 2001; 15: 1-9.

128. Donnan GA, Davis SM. Aspirin therapy should be first line: probably, but watch this this space. Stroke 2002; 33: 2139-40.

129. Komoike Y, Takeeda M, Tanaka A, Kato S, Takeuchi K..Prevention by parenteral aspirin of indomethacin-induced gastric lesions in rats: mediation by salicylic acid. Dig Dis Sci 2002; 47: 1538-45.

130. Koki AT, Masferrer JL. Celecoxib: a specific COX-2 inhibitor with anticancer properties. Cancer Control 2002; 9 (2 Suppl): 28-35.

131. Horton JK, Williams AS, Smith-Phillips Z, Martin RC, O’Beirne G. Intracellular measurement of prostaglandin E2: effect of anti-inflammatory drugs on cyclooxygenas e activity and prostanoid expression. Anal Biochem 1999; 271: 18-28.

132. Su C, Wang MY, Nowicki D, Jensen J, Anderson G. Selective COX-2 inhibition of Morinda citrifolia (Noni) in vitro. The proceedings of the Eicosanoids and other bioactive lipids in cancer, inflammation and related disease. The 7th Annual Conference, 2001 Oct 14-17. Loews Vanderbilt Plaza, Nashville, Tennessee, USA.

133. Zhang LD, Zhang YL, Xu SH, Zhou G, Jin SB. Traditional Chinese medicine typing of affective disorders and treatment. Am J Chin Med 1994; 22: 321-7.

134. Chang IM. Anti-aging and health-promoting constituents derived from traditional oriental herbal remedies: information retrieval using the TradiMed 2000 DB. Ann NY Acad Sci 2001; 928: 281-6.

135. Chen J, Weng W. Medicinal food: the Chinese perspective. J Med Food 1998; 1: 117-22.

136. Weng WJ, Chen JS. The eastern perspective on functional foods based on traditional Chinese medicine. Nutrition Rev 1996; 54: S11-6.

137. Cheng TO. Hippocrates , cardiology, Confucius and the yellow emperor. Int J Cardiol 2001; 81: 219-33.